Kirjoita osake tai kryptovaluutta hakupalkkiin saadaksesi yhteenvedon
Thyrocare Technologies Limited
THYROCAREThyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India. It operates through three segments: Diagnostic Testing Services, Imaging Services, and Others. The company conducts various medical diagnostic tests and profiles of tests that focuses on early detection and management of disorders and diseases, including thyroid, growth, metabolism, auto-immunity, diabetes, anaemia, cardiovascular, infertility, and various infectious diseases. Its profiles of tests include profiles of tests administered under its Aarogyam brand, which offers patients a suite of wellness and preventive health care tests. The company sells glucometer and glucostrips under the brand name Sugarscan; consumables; and radiopharmaceutical products. Thyrocare Technologies Limited was founded in 1996 and is based in Navi Mumbai, India. Thyrocare Technologies Limited is a subsidiary of Docon Technologies Private Limited. Address: D/37-3, TTC Industrial Area, Navi Mumbai, India, 400703
Analytics
WallStreetin tavoitehinta
66 195.67 INRP/E-suhde
59.8829Osinkotuotto
1.86 %Kuluva vuosi
Edellinen vuosi
Nykyinen vuosineljännes
Viimeinen vuosineljännes
Kuluva vuosi
Edellinen vuosi
Nykyinen vuosineljännes
Viimeinen vuosineljännes
Avainluvut THYROCARE
Osinkoanalytiikka THYROCARE
Osinkojen kasvu 5 vuoden aikana
80 %Jatkuva kasvu
1 vuosiMaksusuhde 5 vuoden keskiarvo
96 %Osinkohistoria THYROCARE
Osakkeen arvostus THYROCARE
Talousasiat THYROCARE
Tuloksia | 2019 | Dynamiikka |